Skip to main content
Jinyu Bio-Technology Co.,Ltd. logo

Jinyu Bio-Technology Co.,Ltd. — Investor Relations & Filings

Ticker · 600201 ISIN · CNE000000Y37 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,777 across all filing types
Latest filing 2017-04-24 Audit Report / Informat…
Country CN China
Listing Shanghai Stock Exchange 600201

About Jinyu Bio-Technology Co.,Ltd.

http://jinyubiotech.com/

Jinyu Bio-Technology Co., Ltd. focuses on the research, development, and manufacturing of veterinary biological products and pharmaceuticals. The company is a prominent supplier of animal vaccines, particularly specializing in Foot-and-Mouth Disease (FMD) vaccines, brucellosis vaccines, and solutions for swine and poultry diseases. It utilizes advanced biotechnology platforms, including large-scale suspension culture and high-efficiency purification processes, to produce high-titer, high-purity biologicals. The organization operates sophisticated research facilities and Biosafety Level 3 (P3) laboratories to support the development of diagnostic reagents and preventive treatments. Its operations center on enhancing animal health through scientific innovation, providing comprehensive disease control strategies for the global livestock industry and large-scale agricultural operations.

Recent filings

Filing Released Lang Actions
2016年度内部控制评价报告
Audit Report / Information Classification · 95% confidence The document is titled '2016 年度内部控制评价报告' which translates to '2016 Annual Internal Control Evaluation Report'. It discusses the evaluation of the company's internal control effectiveness as of December 31, 2016, including financial reporting internal control defects, non-financial internal control defects, and related audit opinions. The content is focused on internal control evaluation rather than full financial statements or annual performance. It is a standalone report on internal control evaluation, which aligns with the definition of an Audit Report / Information (AR) as it covers audit-related internal control results and applied standards but is not a full Annual Report (10-K). The document length is 3628 characters, which is relatively short but contains substantive evaluation content, not just an announcement. Therefore, the best classification is AR with high confidence. FY 2016
2017-04-24 Chinese
监事会关于公司2017年度限制性股票股权激励计划相关事项的核查意见
Board/Management Information Classification · 95% confidence The document is a supervisory board's verification opinion on the company's 2017 restricted stock equity incentive plan. It discusses compliance with relevant laws and regulations, the plan's implementation, and its benefits to the company and shareholders. There is no financial data, earnings information, or report publication announcement. The content relates to governance and management oversight of an equity incentive plan, which fits best under Board/Management Information (MANG) as it involves management-level decisions and disclosures about stock incentive plans.
2017-04-24 Chinese
东北证券股份有限公司关公司使用部分闲置募集资金进行现金管理的核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed opinion report from a sponsoring securities firm regarding the use of idle raised funds by a company for cash management purposes. It references regulatory guidelines on the management and use of raised funds, details the approval process by the company's board and independent directors, and provides an audit opinion on compliance and risk control. The document does not contain financial statements or quarterly/yearly financial results but is a formal verification and opinion on a specific financial management activity related to raised funds. It is not an announcement of a report publication but a substantive verification report. This fits the definition of an Audit Report / Information (AR), as it is a standalone audit/verification report related to regulatory compliance and fund usage, not a full annual or interim report or earnings release.
2017-04-24 Chinese
关于筹划股权激励事项的停牌公告
Capital/Financing Update Classification · 95% confidence The document is a short announcement regarding the suspension of trading (停牌公告) due to the company's plan to implement an equity incentive scheme (股权激励事项). It mentions the stock suspension dates and the intention to announce the equity incentive plan draft later. There is no financial data, report, or detailed presentation included. The document is an announcement related to capital/financing activities (equity incentive plan) but is specifically about the trading suspension notice due to this plan. Given the content and length, it fits best under Capital/Financing Update (CAP).
2017-04-20 Chinese
关于子公司取得新兽药注册证书的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the acquisition of a new veterinary drug registration certificate by a subsidiary. It details the product, its development, market background, and expected impact on the company. The document is short (1338 characters) and does not contain financial statements or detailed financial data. It is an announcement of a regulatory approval related to product development, not a financial report or management discussion. It does not fit into categories like Annual Report, Interim Report, or Earnings Release. It is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement about a new product registration certificate.
2017-02-22 Chinese
关于全资子公司获得国家科学技术进步奖二等奖的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by a company about its wholly-owned subsidiary receiving a national science and technology progress award. It includes no financial data, no mention of financial results, no regulatory filings, no meeting materials, no voting results, no management changes, no capital or financing updates, and no legal proceedings. The document is a brief announcement of an award received, which does not fit into any specific financial report category. It is a general regulatory announcement about company achievements and is best classified under Regulatory Filings (RNS). The document length is short and it is not a report or presentation but an announcement.
2017-01-10 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.